These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8105936)

  • 1. Hypertonic saline compresses: therapy for complicated exit-site infections.
    Strauss FG; Holmes DL; Nortman DF; Friedman S
    Adv Perit Dial; 1993; 9():248-50. PubMed ID: 8105936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mycobacterial exit-site infections in patients on continuous ambulatory peritoneal dialysis.
    Kleinpeter MA; Krane NK
    Adv Perit Dial; 2001; 17():172-5. PubMed ID: 11510269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
    Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
    Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
    Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
    Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exit site infections: systematic microbiologic and quality control are needed.
    Freitas C; Rodrigues A; Carvalho MJ; Cabrita A
    Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
    Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
    Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
    Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].
    Kopriva-Altfahrt G; Moser E; Prokschi A; Kraus B; Kovarik J
    Wien Klin Wochenschr; 2005; 117 Suppl 6():73-82. PubMed ID: 16437337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Aug; 20(8):1702-6. PubMed ID: 15855200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparison of exit-site care with normal saline and povidone-iodine in preventing exit-site infection and peritonitis in children on chronic peritoneal dialysis treatment.
    Yavascan O; Anil M; Kara OD; Bal A; Akcan N; Senturk S; Unturk S; Aksu N
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):931-4. PubMed ID: 21912021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cluster of rapidly growing mycobacterial peritoneal dialysis catheter exit-site infections.
    Tse KC; Lui SL; Cheng VC; Yip TP; Lo WK
    Am J Kidney Dis; 2007 Jul; 50(1):e1-5. PubMed ID: 17591517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
    J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Pseudomonas aeruginosa exit-site and tunnel infections: a single center's experience.
    Szabo T; Siccion Z; Izatt S; Vas SI; Bargman J; Oreopoulos DG
    Adv Perit Dial; 1999; 15():209-12. PubMed ID: 10682104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single center experience in successful prevention of exit-site infection in patients on peritoneal dialysis.
    Thokhonelidze I; Maglakelidze N; Sarishvili N; Kasradze T; Dalakishvili K
    Georgian Med News; 2015 Apr; (241):54-8. PubMed ID: 25953940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection.
    Lui SL; Li FK; Lo CY; Lo WK
    Adv Perit Dial; 2000; 16():195-7. PubMed ID: 11045292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
    Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
    Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3% Amuchina is as effective as the 50% concentration in the prevention of exit-site infection in children on chronic peritoneal dialysis.
    Grosman MD; Mosquera VM; Hernandez MG; Agostini S; Adragna M; Sojo ET
    Adv Perit Dial; 2005; 21():148-50. PubMed ID: 16686307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ultraviolet rays on the prevention of exit-site infections.
    Shimomura A; Tahara D; Tominaga M; Uchigiri S; Yamaguchi Y; Ishioka H; Nakahata A
    Adv Perit Dial; 1995; 11():152-6. PubMed ID: 8534692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.